跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
德思卓 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Doravirine lamivudine and tenofovir disoproxil fumarate Tablets
Approved
化学药品
Doravirine lamivudine and tenofovir disoproxil fumarate Tablets
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Jul 21, 2025
Approval ID
887ryqYq3bx
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
887ryqYq3bx
Approval Number
国药准字HJ20200066
Generic Name
多拉米替片
Generic Name En
Doravirine lamivudine and tenofovir disoproxil fumarate Tablets
Brand Name
德思卓
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含多拉韦林100mg、拉米夫定300mg和富马酸替诺福韦二吡呋酯300mg
Reg Date
2025-07-21
Expired Date
2030-07-20
Company Name
Merck Sharp & Dohme BV
Production Company Name
MSD International GmbH
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/msd-international-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 21, 2025
Approval ID
887ryqYq3bx
Type
化学药品
Back to NMPA Approvals